CHEK2 and breast carcinoma: Genetic testing revealed a pathogenic <i>CHEK2</i> nonsense variant (p.Trp411*), a likely pathogenic <i>MSH6</i> frameshift variant, and a breast cancer PRS in the 99th percentile.